Correlation Between Artelo Biosciences and Oric Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Artelo Biosciences and Oric Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Artelo Biosciences and Oric Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Artelo Biosciences and Oric Pharmaceuticals, you can compare the effects of market volatilities on Artelo Biosciences and Oric Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Artelo Biosciences with a short position of Oric Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Artelo Biosciences and Oric Pharmaceuticals.

Diversification Opportunities for Artelo Biosciences and Oric Pharmaceuticals

0.26

Correlation Coefficient

Artelo Biosciences  Oric Pharmaceuticals

Modest diversification

The 3 months correlation between Artelo and Oric is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Artelo Biosciences and Oric Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oric Pharmaceuticals and Artelo Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Artelo Biosciences are associated (or correlated) with Oric Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oric Pharmaceuticals has no effect on the direction of Artelo Biosciences i.e., Artelo Biosciences and Oric Pharmaceuticals go up and down completely randomly.

Pair Corralation between Artelo Biosciences and Oric Pharmaceuticals

Given the investment horizon of 90 days Artelo Biosciences is expected to under-perform the Oric Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Artelo Biosciences is 1.09 times less risky than Oric Pharmaceuticals. The stock trades about -0.01 of its potential returns per unit of risk. The Oric Pharmaceuticals is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  589.00  in Oric Pharmaceuticals on September 26, 2024 and sell it today you would earn a total of  230.00  from holding Oric Pharmaceuticals or generate 39.05% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Artelo Biosciences  vs.  Oric Pharmaceuticals

Artelo Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Artelo Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Artelo Biosciences is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Oric Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oric Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Artelo Biosciences and Oric Pharmaceuticals

The main advantage of trading using opposite Artelo Biosciences and Oric Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Artelo Biosciences position performs unexpectedly, Oric Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oric Pharmaceuticals will offset losses from the drop in Oric Pharmaceuticals' long position.

The idea behind Artelo Biosciences and Oric Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.